HepaTx Corporation Employee Directory
Biotechnology ResearchCalifornia, United States2-10 Employees
HepaTx Corporation is a biotechnology research company focused on developing cell therapies aimed at treating late-stage liver disease. Its work centers on regenerative medicine approaches designed to repair diseased and damaged liver tissue, with an emphasis on off-the-shelf cell therapy candidates derived from adipose tissue–derived sources. Based in Palo Alto, California, the organization operates at a preclinical stage and collaborates with notable researchers through its Scientific Advisory Board to advance its therapeutic programs. Target customers and stakeholders include the medical community and researchers seeking new treatment modalities for chronic liver disease, as the firm aims to provide alternatives that could free patients from ongoing liver impairment. The company positions itself within the biotechnology research sector, pursuing innovative cellular therapies as a means to address unmet clinical needs in hepatology. A recent development includes the appointment of new members to its Scientific Advisory Board, underscoring ongoing efforts to strengthen scientific guidance while continuing preclinical work.